Cultures of HEp-2 cells persistently infected by human respiratory syncytial virus differ in chemokine expression and resistance to apoptosis as compared to lytic infections of the same cell type

Virology

Volumn 388, Issue 1, 2009, Pages 31-41

  Martínez, Isidoro ^a,b   Lombardía, Luis ^c   Herranz, Cristina ^a   García Barreno, Blanca ^a,b   Domínguez, Orlando ^c   Melero, José A ^a,b  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Apoptosis; Chemokine; Cytokine; Microarrays; Persistence; Respiratory syncytial virus

Indexed keywords

CASPASE 3; CASPASE 8; CASPASE 9; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; GENE PRODUCT; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PROTEIN BCL X; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 1; VIRUS ANTIGEN;

APOPTOSIS; ARTICLE; CELL CLONE; CELL SURVIVAL; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOLYSIS; DOWN REGULATION; ENZYME ACTIVATION; GENE EXPRESSION; HEP 2 CELL; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; UPREGULATION; VIRUS CELL INTERACTION; VIRUS INFECTION; WILD TYPE;

APOPTOSIS; CELL LINE; CHEMOKINES; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMANS; RESPIRATORY SYNCYTIAL VIRUSES; VIRUS REPLICATION;

HUMAN RESPIRATORY SYNCYTIAL VIRUS; HYDRANGEA RINGSPOT VIRUS; RESPIRATORY SYNCYTIAL VIRUS;

EID: 67349100136     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.03.008     Document Type: Article

References (57)

1. Baldridge P., and Senterfit L.B. Persistent infection of cells in culture by respiratory syncytial virus. Proc. Soc. Exp. Biol. Med. 151 (1976) 684-688
2. Bangham C.R., and McMichael A.J. Specific human cytotoxic T cells recognize B-cell lines persistently infected with respiratory syncytial virus. Proc. Natl. Acad. Sci. U. S. A. 83 (1986) 9183-9187
3. Bitko V., Shulyayeva O., Mazumder B., Musiyenko A., Ramaswamy M., Look D.C., and Barik S. Nonstructural proteins of respiratory syncytial virus suppress premature apoptosis by an NF-kappaB-dependent, interferon-independent mechanism and facilitate virus growth. J. Virol. 81 (2007) 1786-1795
4. Bramley A.M., Vitalis T.Z., Wiggs B.R., and Hegele R.G. Effects of respiratory syncytial virus persistence on airway responsiveness and inflammation in guinea-pigs. Eur. Respir. J. 14 (1999) 1061-1067
5. Brooks D.G., Trifilo M.J., Edelmann K.H., Teyton L., McGavern D.B., and Oldstone M.B. Interleukin-10 determines viral clearance or persistence in vivo. Nat. Med. 12 (2006) 1301-1309
6. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354 (2006) 610-621
7. Collins P., and Crowe J. Respiratory syncytial virus and metapneumovirus. In: Knipe D., and Howley P. (Eds). Fields Virology. Fifth ed. (2007), Lippincott Williams and Wilkins, Philadelphia 1601-1646
8. Couch R.B., Englund J.A., and Whimbey E. Respiratory viral infections in immunocompetent and immunocompromised persons. Am. J. Med. 102 (1997) 2-9 discussion 25-26
9. Cubie H.A., Duncan L.A., Marshall L.A., and Smith N.M. Detection of respiratory syncytial virus nucleic acid in archival postmortem tissue from infants. Pediatr. Pathol. Lab. Med. 17 (1997) 927-938
10. Culley F.J., Pennycook A.M., Tregoning J.S., Hussell T., and Openshaw P.J. Differential chemokine expression following respiratory virus infection reflects Th1- or Th2-biased immunopathology. J. Virol. 80 (2006) 4521-4527
11. Danial N.N., and Korsmeyer S.J. Cell death: critical control points. Cell 116 (2004) 205-219
12. de la Torre J.C., Martinez-Salas E., Diez J., and Domingo E. Extensive cell heterogeneity during persistent infection with foot-and-mouth disease virus. J. Virol. 63 (1989) 59-63
13. Di Rosa F., and Barnaba V. Persisting viruses and chronic inflammation: understanding their relation to autoimmunity. Immunol. Rev. 164 (1998) 17-27
14. Eckardt-Michel J., Lorek M., Baxmann D., Grunwald T., Keil G.M., and Zimmer G. The fusion protein of respiratory syncytial virus triggers p53-dependent apoptosis. J. Virol. 82 (2008) 3236-3249
15. Ejrnaes M., Filippi C.M., Martinic M.M., Ling E.M., Togher L.M., Crotty S., and von Herrath M.G. Resolution of a chronic viral infection after interleukin-10 receptor blockade. J. Exp. Med. 203 (2006) 2461-2472
16. Fernie B.F., Ford E.C., and Gerin J.L. The development of Balb/c cells persistently infected with respiratory syncytial virus: presence of ribonucleoprotein on the cell surface. Proc. Soc. Exp. Biol. Med. 167 (1981) 83-86
17. Garcia-Barreno B., Palomo C., Penas C., Delgado T., Perez-Brena P., and Melero J.A. Marked differences in the antigenic structure of human respiratory syncytial virus F and G glycoproteins. J. Virol. 63 (1989) 925-932
18. Gonzalez-Reyes L., Ruiz-Arguello M.B., Garcia-Barreno B., Calder L., Lopez J.A., Albar J.P., Skehel J.J., Wiley D.C., and Melero J.A. Cleavage of the human respiratory syncytial virus fusion protein at two distinct sites is required for activation of membrane fusion. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 9859-9864
19. Groskreutz D.J., Monick M.M., Yarovinsky T.O., Powers L.S., Quelle D.E., Varga S.M., Look D.C., and Hunninghake G.W. Respiratory syncytial virus decreases p53 protein to prolong survival of airway epithelial cells. J. Immunol. 179 (2007) 2741-2747
20. Guerrero-Plata A., Ortega E., and Gomez B. Persistence of respiratory syncytial virus in macrophages alters phagocytosis and pro-inflammatory cytokine production. Viral Immunol. 14 (2001) 19-30
21. Hay S., and Kannourakis G. A time to kill: viral manipulation of the cell death program. J. Gen. Virol. 83 (2002) 1547-1564
22. Hegele R.G., Hayashi S., Bramley A.M., and Hogg J.C. Persistence of respiratory syncytial virus genome and protein after acute bronchiolitis in guinea pigs. Chest 105 (1994) 1848-1854
23. Hobson L., and Everard M.L. Persistent of respiratory syncytial virus in human dendritic cells and influence of nitric oxide. Clin. Exp. Immunol. 151 (2007) 359-366
24. Hodes D.S., Weldy P.L., and Doundoulakis J.H. Establishment of persistent infection by parainfluenza virus type 3: role of a syncytium inhibitor. J. Gen. Virol. 44 (1979) 515-523
25. Inglot A.D., Albin M., and Chudzio T. Persistent infection of mouse cells with Sindbis virus: role of virulence of strains, auto-interfering particles and interferon. J. Gen. Virol. 20 (1973) 105-110
26. Isaia G., Teodosiu O., Popescu G., Athanasiu P., Sternberg I., and Dumitriu Z. Persistence of viruses in the nasopharynx of apparently healthy children aged 0-5 years. Results of investigations performed in 1982-83. Virologie 36 (1985) 175-179
27. Kim E.Y., Battaile J.T., Patel A.C., You Y., Agapov E., Grayson M.H., Benoit L.A., Byers D.E., Alevy Y., Tucker J., Swanson S., Tidwell R., Tyner J.W., Morton J.D., Castro M., Polineni D., Patterson G.A., Schwendener R.A., Allard J.D., Peltz G., and Holtzman M.J. Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat. Med. 14 (2008) 633-640
28. Krishnan S., Halonen M., and Welliver R.C. Innate immune responses in respiratory syncytial virus infections. Viral Immunol. 17 (2004) 220-233
29. Lindemans C.A., Coffer P.J., Schellens I.M., de Graaff P.M., Kimpen J.L., and Koenderman L. Respiratory syncytial virus inhibits granulocyte apoptosis through a phosphatidylinositol 3-kinase and NF-kappaB-dependent mechanism. J. Immunol. 176 (2006) 5529-5537
30. Luo B.H., Carman C.V., and Springer T.A. Structural basis of integrin regulation and signaling. Annu. Rev. Immunol. 25 (2007) 619-647
31. Martinez I., Dopazo J., and Melero J.A. Antigenic structure of the human respiratory syncytial virus G glycoprotein and relevance of hypermutation events for the generation of antigenic variants. J. Gen. Virol. 78 Pt 10 (1997) 2419-2429
32. Martinez I., Bustos J., and Melero J.A. Reduced expression of surface glycoproteins in mouse fibroblasts persistently infected with human respiratory syncytial virus (HRSV). Arch. Virol. 146 (2001) 669-683
33. Martinez I., Lombardia L., Garcia-Barreno B., Dominguez O., and Melero J.A. Distinct gene subsets are induced at different time points after human respiratory syncytial virus infection of A549 cells. J. Gen. Virol. 88 (2007) 570-581
34. Mills B.G., Singer F.R., Weiner L.P., and Holst P.A. Immunohistological demonstration of respiratory syncytial virus antigens in Paget disease of bone. Proc. Natl. Acad. Sci. U. S. A. 78 (1981) 1209-1213
35. Monick M.M., Cameron K., Staber J., Powers L.S., Yarovinsky T.O., Koland J.G., and Hunninghake G.W. Activation of the epidermal growth factor receptor by respiratory syncytial virus results in increased inflammation and delayed apoptosis. J. Biol. Chem. 280 (2005) 2147-2158
36. O'Donnell D.R., Milligan L., and Stark J.M. Induction of CD95 (Fas) and apoptosis in respiratory epithelial cell cultures following respiratory syncytial virus infection. Virology 257 (1999) 198-207
37. Palma E.L., and Huang A. Cyclic production of vesicular stomatitis virus caused by defective interfering particles. J. Infect. Dis. 129 (1974) 402-410
38. Panuska J.R., Cirino N.M., Midulla F., Despot J.E., McFadden Jr. E.R., and Huang Y.T. Productive infection of isolated human alveolar macrophages by respiratory syncytial virus. J. Clin. Invest. 86 (1990) 113-119
39. Peeples M., and Levine S. Characteristics of a persistent respiratory syncytial virus infection in HeLa cells. Virology 113 (1981) 141-149
40. Perez-Yarza E.G., Moreno A., Lazaro P., Mejias A., and Ramilo O. The association between respiratory syncytial virus infection and the development of childhood asthma: a systematic review of the literature. Pediatr. Infect. Dis. J. 26 (2007) 733-739
41. P'Ringle C.R., Shirodaria P.V., Cash P., Chiswell D.J., and Malloy P. Initiation and maintenance of persistent infection by respiratory syncytial virus. J. Virol. 28 (1978) 199-211
42. Riedel F., Oberdieck B., Streckert H.J., Philippou S., Krusat T., and Marek W. Persistence of airway hyperresponsiveness and viral antigen following respiratory syncytial virus bronchiolitis in young guinea-pigs. Eur. Respir. J. 10 (1997) 639-645
43. Sarmiento R.E., Tirado R., and Gomez B. Characteristics of a respiratory syncytial virus persistently infected macrophage-like culture. Virus Res. 84 (2002) 45-58
44. Schwarze J., O'Donnell D.R., Rohwedder A., and Openshaw P.J. Latency and persistence of respiratory syncytial virus despite T cell immunity. Am. J. Respir. Crit. Care Med. 169 (2004) 801-805
45. Seemungal T., Harper-Owen R., Bhowmik A., Moric I., Sanderson G., Message S., Maccallum P., Meade T.W., Jeffries D.J., Johnston S.L., and Wedzicha J.A. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164 (2001) 1618-1623
46. Streckert H.J., Philippou S., and Riedel F. Detection of respiratory syncytial virus (RSV) antigen in the lungs of guinea pigs 6 weeks after experimental infection and despite of the production of neutralizing antibodies. Arch. Virol. 141 (1996) 401-410
47. Stupack D.G. Integrins as a distinct subtype of dependence receptors. Cell Death Differ. 12 (2005) 1021-1030
48. Takada Y., Ye X., and Simon S. The integrins. Genome Biol. 8 (2007) 215
49. Tan Y.R., Yang T., Liu S.P., Xiang Y., Qu F., Liu H.J., and Qin X.Q. Pulmonary peptidergic innervation remodeling and development of airway hyperresponsiveness induced by RSV persistent infection. Peptides 29 (2008) 47-56
50. Thomas K.W., Monick M.M., Staber J.M., Yarovinsky T., Carter A.B., and Hunninghake G.W. Respiratory syncytial virus inhibits apoptosis and induces NF-kappa B activity through a phosphatidylinositol 3-kinase-dependent pathway. J. Biol. Chem. 277 (2002) 492-501
51. Thomas L.H., Friedland J.S., and Sharland M. Chemokines and their receptors in respiratory disease: a therapeutic target for respiratory syncytial virus infection. Expert Rev. Anti. Infect. Ther. 5 (2007) 415-425
52. Tirado R., Ortega A., Sarmiento R.E., and Gomez B. Interleukin-8 mRNA synthesis and protein secretion are continuously up-regulated by respiratory syncytial virus persistently infected cells. Cell. Immunol. 233 (2005) 61-71
53. Tusher V.G., Tibshirani R., and Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc. Natl. Acad. Sci. U. S. A. 98 (2001) 5116-5121
54. Valdovinos M.R., and Gomez B. Establishment of respiratory syncytial virus persistence in cell lines: association with defective interfering particles. Intervirology 46 (2003) 190-198
55. Wald O., Weiss I.D., Galun E., and Peled A. Chemokines in hepatitis C virus infection: pathogenesis, prognosis and therapeutics. Cytokine 39 (2007) 50-62
56. Wilkinson T.M., Donaldson G.C., Johnston S.L., Openshaw P.J., and Wedzicha J.A. Respiratory syncytial virus, airway inflammation, and FEV1 decline in patients with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 173 (2006) 871-876
57. Winter C., Taut K., Srivastava M., Langer F., Mack M., Briles D.E., Paton J.C., Maus R., Welte T., Gunn M.D., and Maus U.A. Lung-specific overexpression of CC chemokine ligand (CCL) 2 enhances the host defense to Streptococcus pneumoniae infection in mice: role of the CCL2-CCR2 axis. J. Immunol. 178 (2007) 5828-5838